{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T06:33:08Z","timestamp":1791181988814,"version":"4.1.0"},"reference-count":56,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2004,6,1]],"date-time":"2004-06-01T00:00:00Z","timestamp":1086048000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathologie Biologie"],"published-print":{"date-parts":[[2004,6]]},"DOI":"10.1016\/j.patbio.2004.04.012","type":"journal-article","created":{"date-parts":[[2004,5,8]],"date-time":"2004-05-08T11:37:11Z","timestamp":1084016231000},"page":"294-299","source":"Crossref","is-referenced-by-count":45,"title":["Interest of interferon alpha in systemic mastocytosis. The French experience and review of the literature"],"prefix":"10.1016","volume":"52","author":[{"given":"J","family":"Simon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O","family":"Lortholary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Caillat-Vigneron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Rapha\u00ebl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Bri\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Bar\u00e8te","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O","family":"Hermine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ph","family":"Casassus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.patbio.2004.04.012_BIB1","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/00005792-198811000-00001","article-title":"Systemic mast cell disease. Analysis of 58\u00a0cases and literature review","volume":"67","author":"Travis","year":"1988","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.patbio.2004.04.012_BIB2","first-page":"125","article-title":"Systemic mastocytosis and malignant mastocytosis","volume":"19","author":"Lortholary","year":"1990","journal-title":"Presse Med"},{"key":"10.1016\/j.patbio.2004.04.012_BIB3","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0145-2126(01)00038-8","article-title":"Diagnostic criteria and classification of mastocytosis: a consensus proposal","volume":"25","author":"Valent","year":"2001","journal-title":"Leuk Res"},{"key":"10.1016\/j.patbio.2004.04.012_BIB4","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1046\/j.1365-2141.2003.04575.x","article-title":"Diagnosis and treatment of systemic mastocytosis: state of the art","volume":"122","author":"Valent","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1016\/j.patbio.2004.04.012_BIB5","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/ng0396-312","article-title":"Somatic c-Kit-activating mutation in urticaria pigmentosa and aggressive mastocytosis: establishment of clonality in a human mast cell neoplasm","volume":"12","author":"Longley","year":"1996","journal-title":"Nat Genet"},{"key":"10.1016\/j.patbio.2004.04.012_BIB6","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s00282-997-0114-4","article-title":"c-Kit mutations and mast cell disorders. A model of activating mutations of growth factor receptors","volume":"39","author":"Pignon","year":"1997","journal-title":"Hematol Cell Ther"},{"key":"10.1016\/j.patbio.2004.04.012_BIB7","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1159\/000237541","article-title":"c-Kit mutation in a population of patients with mastocytosis","volume":"113","author":"Nagata","year":"1997","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.patbio.2004.04.012_BIB8","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/sj.leu.2400906","article-title":"Elevated expression of the proto-oncogene c-Kit in patients with mastocytosis","volume":"12","author":"Nagata","year":"1998","journal-title":"Leukemia"},{"key":"10.1016\/j.patbio.2004.04.012_BIB9","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1073\/pnas.96.4.1609","article-title":"Activating and dominant inactivating c-Kit catalytic domain mutations in distinct clinical forms of human mastocytosis","volume":"96","author":"Longley","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.patbio.2004.04.012_BIB10","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/jlb.67.2.135","article-title":"c-Kit and c-Kit mutations in mastocytosis and other hematological diseases","volume":"67","author":"Boissan","year":"2000","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.patbio.2004.04.012_BIB11","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0145-2126(01)00028-5","article-title":"Classes of c-Kit activating mutations: proposed mechanisms of action and implications for disease classification and therapy","volume":"25","author":"Longley","year":"2001","journal-title":"Leuk Res"},{"key":"10.1016\/j.patbio.2004.04.012_BIB12","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1159\/000048179","article-title":"Kit and c-Kit mutations in mastocytosis: a short overview with special reference to novel molecular and diagnostic concepts","volume":"127","author":"Feger","year":"2002","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.patbio.2004.04.012_BIB13","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1046\/j.1365-2141.2002.03944.x","article-title":"Treatment of adult systemic mastocytosis with interferon-\u03b1: results of a multicentre phase II trial on 20\u00a0patients","volume":"119","author":"Casassus","year":"2002","journal-title":"Br J Heamatol"},{"key":"10.1016\/j.patbio.2004.04.012_BIB14","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/S0248-8663(03)00141-3","article-title":"Treatment of systemic mastocytosis","volume":"24","author":"Marrache","year":"2003","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.patbio.2004.04.012_BIB15","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0145-2126(01)00039-X","article-title":"Treatment of mastocytosis: pharmacological basis and current concepts","volume":"25","author":"Marone","year":"2001","journal-title":"Leuk Res"},{"key":"10.1016\/j.patbio.2004.04.012_BIB16","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0889-8588(05)70302-6","article-title":"New approaches to therapy to mastocytosis. A case for treatment with kit kinase inhibitors","volume":"14","author":"Longley","year":"2000","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.patbio.2004.04.012_BIB17","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/j.1365-2133.1990.tb04488.x","article-title":"Congenital systemic mastocytosis","volume":"123","author":"Potter","year":"1990","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.patbio.2004.04.012_BIB18","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1046\/j.1365-2133.1998.02131.x","article-title":"Response of severe systemic mastocytosis to interferon alpha","volume":"138","author":"Butterfield","year":"1998","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.patbio.2004.04.012_BIB19","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/j.1365-2133.1995.tb08689.x","article-title":"Interferon-\u03b1 in combination with corticosteroids improves systemic mast cell disease","volume":"132","author":"Delaporte","year":"1995","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.patbio.2004.04.012_BIB20","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1182\/blood.V69.5.1280.1280","article-title":"Clinical investigation of human alpha interferon in chronic myelogenous leukemia","volume":"69","author":"Talpaz","year":"1987","journal-title":"Blood"},{"key":"10.1016\/j.patbio.2004.04.012_BIB21","doi-asserted-by":"crossref","first-page":"532","DOI":"10.7326\/0003-4819-114-7-532","article-title":"Interferon-alpha produces sustained cytogenetic responses in chronic myelogenous leukemia Philadelphia chromosome-positive patients","volume":"114","author":"Talpaz","year":"1991","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.patbio.2004.04.012_BIB22","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1056\/NEJM199202273260907","article-title":"Response to interferon alfa-2b in a patient with systemic mastocytosis","volume":"326","author":"Kluin-Nelemans","year":"1992","journal-title":"New Engl J Med"},{"key":"10.1016\/j.patbio.2004.04.012_BIB23","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0145-2126(02)00168-6","article-title":"Aggressive systemic mastocytosis and related mast cell disorders: current treatment options and proposed response criteria","volume":"27","author":"Valent","year":"2003","journal-title":"Leuk Res"},{"key":"10.1016\/j.patbio.2004.04.012_BIB24","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/ajh.2830470121","article-title":"Long-term response to interferon-alpha in a patient with systemic mastocytosis and chronic myelomonocytic leukemia (letter)","volume":"47","author":"Pulik","year":"1994","journal-title":"Am J Hematol"},{"key":"10.1016\/j.patbio.2004.04.012_BIB25","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/0190-9622(95)91545-1","article-title":"Systemic mastocytosis associated with chronic myelomonocytic leukemia: clinical features and response to interferon alfa therapy","volume":"32","author":"Petit","year":"1995","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.patbio.2004.04.012_BIB26","doi-asserted-by":"crossref","first-page":"501","DOI":"10.3109\/10428199609054789","article-title":"Treatment of three patients with systemic mastocytosis with interferon alpha-2b","volume":"22","author":"Worobec","year":"1996","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.patbio.2004.04.012_BIB27","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1093\/rheumatology\/35.9.898","article-title":"Severe osteoporosis due to systemic mast cell disease: successful treatment with interferon alpha-2b","volume":"35","author":"Lehmann","year":"1996","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.patbio.2004.04.012_BIB28","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/BF00663015","article-title":"Successful treatment of osteoporosis in systemic mastocytosis with interferon alpha-2b","volume":"72","author":"Weide","year":"1996","journal-title":"Ann Hematol"},{"issue":"4","key":"10.1016\/j.patbio.2004.04.012_BIB29","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1046\/j.1365-2133.1998.02190.x","article-title":"Tripe palms associated with systemic mastocytosis: the role of transforming growth factor-alpha and efficacy of interferon-alfa","volume":"138","author":"Chosidow","year":"1998","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.patbio.2004.04.012_BIB30","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1056\/NEJM200101253440415","article-title":"Treatment of systemic mast-cell disease with Cladribine (letter)","volume":"344","author":"Tefferi","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.patbio.2004.04.012_BIB31","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/j.1365-2362.1995.tb01754.x","article-title":"Treatment of systemic mastocytosis with interferon-gamma: failure after appearance of anti-IFN-gamma antibodies","volume":"25","author":"Fiehn","year":"1995","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.patbio.2004.04.012_BIB32","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1365-2257.1994.tb00423.x","article-title":"Systemic mastocytosis\u2014a case treated with interferon alpha and radiotherapy","volume":"16","author":"Harrison","year":"1994","journal-title":"Clin Lab Haematol"},{"key":"10.1016\/j.patbio.2004.04.012_BIB33","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/S0190-9622(08)81953-6","article-title":"Interferon treatment of patients with chronic urticaria and mastocytosis","volume":"30","author":"Czarnetzki","year":"1994","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.patbio.2004.04.012_BIB34","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1365-2796.1997.tb00013.x","article-title":"Clinical stable systemic mastocytosis with interferon alpha-2b therapy","volume":"241","author":"H\u00fcbner","year":"1997","journal-title":"J Intern Med"},{"key":"10.1016\/j.patbio.2004.04.012_BIB35","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s002770050428","article-title":"c-Kit mutation and ostopetrosis-like in a patient with systemic mast cell disease","volume":"77","author":"Reinacher-Schick","year":"1998","journal-title":"Ann Hematol"},{"key":"10.1016\/j.patbio.2004.04.012_BIB36","first-page":"205","article-title":"Efficacy of interferon alpha in a case of systemic mastocytosis (letter)","volume":"146","author":"Fain","year":"1995","journal-title":"Ann Med Interne (Paris)"},{"key":"10.1016\/j.patbio.2004.04.012_BIB37","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1365-2133.1995.tb02499.x","article-title":"Treatment of urticaria pigmentosa using interferon alpha","volume":"133","author":"Kolde","year":"1995","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.patbio.2004.04.012_BIB38","doi-asserted-by":"crossref","first-page":"484","DOI":"10.2169\/internalmedicine.37.484","article-title":"Systemic mastocytosis with extensive polypoid lesions in the intestines; successful treatment with interferon-\u03b1","volume":"37","author":"Takasaki","year":"1998","journal-title":"Intern Med"},{"key":"10.1016\/j.patbio.2004.04.012_BIB39","first-page":"64","article-title":"Interferon alpha et pamidronate: a useful combination in the treatment of osteoporosis and systemic mastocytosis (letter)","volume":"27","author":"Brunel","year":"1998","journal-title":"Presse Med"},{"key":"10.1016\/j.patbio.2004.04.012_BIB40","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1159\/000204898","article-title":"Anaphylactic-like syndrome in systemic mastocytosis treated with alpha-2-interferon","volume":"85","author":"Pardini","year":"1991","journal-title":"Acta Haematol"},{"key":"10.1016\/j.patbio.2004.04.012_BIB41","first-page":"606","article-title":"Interferon-\u03b1\u03b2 inhibits IgE-dependant histamine release from rat mast cells","volume":"66","author":"Swieter","year":"1989","journal-title":"Immunology"},{"key":"10.1016\/j.patbio.2004.04.012_BIB42","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/eji.1830200117","article-title":"Specific high-affinity receptors for interferon-\u03b3 on mouse bone marrow-derived mast cells: inhibitory effect of interferon-\u03b3 on mast cell precursors","volume":"20","author":"Nafziger","year":"1990","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.patbio.2004.04.012_BIB43","first-page":"245","article-title":"Inhibition of human mast cell growth and differentiation by interferon gamma-1b","volume":"26","author":"Kirshenbaum","year":"1998","journal-title":"Exp Hematol"},{"key":"10.1016\/j.patbio.2004.04.012_BIB44","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1007\/s002770000206","article-title":"Effects of interferon-\u03b12b treatment on ex vivo differentiation of mast cells from circulating progenitor cells in a patient with systemic mastocytosis","volume":"79","author":"Schernthaner","year":"2000","journal-title":"Ann Hematol"},{"key":"10.1016\/j.patbio.2004.04.012_BIB45","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s002770050604","article-title":"Interferon \u03b1 treatment in systemic mastocytosis","volume":"78","author":"Lehmann","year":"1999","journal-title":"Ann Hematol"},{"key":"10.1016\/j.patbio.2004.04.012_BIB46","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/S0889-8588(03)00089-3","article-title":"Mast cell proliferative disorders: current view on variants recognized by the World Health Organization","volume":"17","author":"Valent","year":"2003","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.patbio.2004.04.012_BIB47","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1056\/NEJM200108023450514","article-title":"Paroxetine for the prevention of depression induced by interferon alpha","volume":"345","author":"Kraus","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.patbio.2004.04.012_BIB48","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1007\/s002770000271","article-title":"Complex karyotype and absence of mutation in the c-Kit receptor in aggressive mastocytosis presenting with pelvic osteolysis, eosinophilia and brain damage","volume":"80","author":"Jost","year":"2001","journal-title":"Ann Hematol"},{"key":"10.1016\/j.patbio.2004.04.012_BIB49","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/sj.onc.1206120","article-title":"Effect of tyrosine kinase inhibitor STI571 on the kinase activity of wild-type and various mutated c-Kit receptors found in mast cell neoplasms","volume":"22","author":"Zermati","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.patbio.2004.04.012_BIB50","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0140-6736(03)14115-3","article-title":"Imatinib for systemic mast-cell disease","volume":"362","author":"Pardanani","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.patbio.2004.04.012_BIB51","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0145-2126(03)00185-1","article-title":"Treatment of systemic mast cell disease with 2-chlorodeoxyadenosine","volume":"28","author":"Pardanani","year":"2004","journal-title":"Leuk Res"},{"key":"10.1016\/j.patbio.2004.04.012_BIB52","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1159\/000048189","article-title":"Mastocytosis: current treatment concepts","volume":"127","author":"Worobec","year":"2002","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.patbio.2004.04.012_BIB53","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/S0145-2126(02)00073-5","article-title":"Cladribine induces immunophenotypical changes in bone marrow mast cells from mastocytosis. Report of a case of mastocytosis associated with a lymphoplasmacytic lymphoma","volume":"26","author":"Escribano","year":"2002","journal-title":"Leuk Res"},{"key":"10.1016\/j.patbio.2004.04.012_BIB54","doi-asserted-by":"crossref","first-page":"4270","DOI":"10.1182\/blood-2003-05-1699","article-title":"Cladribine therapy for systemic mastocytosis","volume":"102","author":"Kluin-Nelemans","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.patbio.2004.04.012_BIB55","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0145-2126(03)00258-3","article-title":"Cladribine activity in systemic mast cell disease: application of biochemistry in the modern area of molecular biology","volume":"28","author":"Nieva","year":"2004","journal-title":"Leuk Res"},{"key":"10.1016\/j.patbio.2004.04.012_BIB56","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1056\/NEJM199707243370402","article-title":"Interferon alfa-2b combined with cytarabine versus interferon alone in chronic myelogenous leukemia","volume":"337","author":"Guilhot","year":"1997","journal-title":"N Engl J Med"}],"container-title":["Pathologie Biologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0369811404000938?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0369811404000938?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,2]],"date-time":"2020-04-02T03:10:10Z","timestamp":1585797010000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0369811404000938"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,6]]},"references-count":56,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2004,6]]}},"alternative-id":["S0369811404000938"],"URL":"https:\/\/doi.org\/10.1016\/j.patbio.2004.04.012","relation":{},"ISSN":["0369-8114"],"issn-type":[{"value":"0369-8114","type":"print"}],"subject":[],"published":{"date-parts":[[2004,6]]}}}